Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.14
MLAB's Cash to Debt is ranked lower than
53% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. MLAB: 0.14 )
MLAB' s 10-Year Cash to Debt Range
Min: 0.14   Max: No Debt
Current: 0.14

Equity to Asset 0.63
MLAB's Equity to Asset is ranked higher than
69% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. MLAB: 0.63 )
MLAB' s 10-Year Equity to Asset Range
Min: 0.63   Max: 0.97
Current: 0.63

0.63
0.97
F-Score: 4
Z-Score: 7.10
M-Score: -2.91
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 28.22
MLAB's Operating margin (%) is ranked higher than
95% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.44 vs. MLAB: 28.22 )
MLAB' s 10-Year Operating margin (%) Range
Min: 28.22   Max: 38.27
Current: 28.22

28.22
38.27
Net-margin (%) 18.20
MLAB's Net-margin (%) is ranked higher than
91% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.65 vs. MLAB: 18.20 )
MLAB' s 10-Year Net-margin (%) Range
Min: 18.06   Max: 25.93
Current: 18.2

18.06
25.93
ROE (%) 16.02
MLAB's ROE (%) is ranked higher than
88% of the 283 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. MLAB: 16.02 )
MLAB' s 10-Year ROE (%) Range
Min: 13.85   Max: 20
Current: 16.02

13.85
20
ROA (%) 12.82
MLAB's ROA (%) is ranked higher than
92% of the 290 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.24 vs. MLAB: 12.82 )
MLAB' s 10-Year ROA (%) Range
Min: 12.13   Max: 18.18
Current: 12.82

12.13
18.18
ROC (Joel Greenblatt) (%) 72.03
MLAB's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.38 vs. MLAB: 72.03 )
MLAB' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 40.43   Max: 83.32
Current: 72.03

40.43
83.32
Revenue Growth (%) 24.70
MLAB's Revenue Growth (%) is ranked higher than
94% of the 248 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. MLAB: 24.70 )
MLAB' s 10-Year Revenue Growth (%) Range
Min: 1.2   Max: 24.7
Current: 24.7

1.2
24.7
EBITDA Growth (%) 22.90
MLAB's EBITDA Growth (%) is ranked higher than
91% of the 210 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.40 vs. MLAB: 22.90 )
MLAB' s 10-Year EBITDA Growth (%) Range
Min: 4.1   Max: 27.8
Current: 22.9

4.1
27.8
EPS Growth (%) 17.50
MLAB's EPS Growth (%) is ranked higher than
85% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. MLAB: 17.50 )
MLAB' s 10-Year EPS Growth (%) Range
Min: 0.7   Max: 24
Current: 17.5

0.7
24
» MLAB's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

MLAB Guru Trades in Q1 2013

Jim Simons 49,000 sh (+16.11%)
Chuck Royce 51,389 sh (unchged)
» More
Q2 2013

MLAB Guru Trades in Q2 2013

Jim Simons 89,200 sh (+82.04%)
Chuck Royce 51,389 sh (unchged)
» More
Q3 2013

MLAB Guru Trades in Q3 2013

Chuck Royce 81,389 sh (+58.38%)
Jim Simons 111,200 sh (+24.66%)
» More
Q4 2013

MLAB Guru Trades in Q4 2013

Jim Simons 126,188 sh (+13.48%)
Chuck Royce 82,089 sh (+0.86%)
» More
» Details

Insider Trades

Latest Guru Trades with MLAB

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2011-03-31 Sold Out $28.1 - $30.69 $ 87.13196%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 39.40
MLAB's P/E(ttm) is ranked lower than
60% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.10 vs. MLAB: 39.40 )
MLAB' s 10-Year P/E(ttm) Range
Min: 10.01   Max: 42.53
Current: 39.4

10.01
42.53
P/B 5.10
MLAB's P/B is ranked lower than
62% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. MLAB: 5.10 )
MLAB' s 10-Year P/B Range
Min: 1.45   Max: 5.52
Current: 5.1

1.45
5.52
P/S 6.37
MLAB's P/S is ranked lower than
76% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.60 vs. MLAB: 6.37 )
MLAB' s 10-Year P/S Range
Min: 2.32   Max: 6.89
Current: 6.37

2.32
6.89
PFCF 26.50
MLAB's PFCF is ranked higher than
61% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.00 vs. MLAB: 26.50 )
MLAB' s 10-Year PFCF Range
Min: 7.22   Max: 37.1
Current: 26.5

7.22
37.1
EV-to-EBIT 25.60
MLAB's EV-to-EBIT is ranked lower than
57% of the 247 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.32 vs. MLAB: 25.60 )
MLAB' s 10-Year EV-to-EBIT Range
Min: 4.9   Max: 29
Current: 25.6

4.9
29
PEG 2.10
MLAB's PEG is ranked higher than
67% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.13 vs. MLAB: 2.10 )
MLAB' s 10-Year PEG Range
Min: 0.43   Max: 3.76
Current: 2.1

0.43
3.76
Shiller P/E 44.10
MLAB's Shiller P/E is ranked lower than
65% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.28 vs. MLAB: 44.10 )
MLAB' s 10-Year Shiller P/E Range
Min: 12.07   Max: 47.58
Current: 44.1

12.07
47.58

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.67
MLAB's Dividend Yield is ranked lower than
74% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. MLAB: 0.67 )
MLAB' s 10-Year Dividend Yield Range
Min: 0.5   Max: 2.6
Current: 0.67

0.5
2.6
Dividend Payout 0.26
MLAB's Dividend Payout is ranked higher than
76% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.33 vs. MLAB: 0.26 )
MLAB' s 10-Year Dividend Payout Range
Min: 0.18   Max: 0.35
Current: 0.26

0.18
0.35
Dividend growth (3y) 8.70
MLAB's Dividend growth (3y) is ranked higher than
78% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.00 vs. MLAB: 8.70 )
MLAB' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 44.2
Current: 8.7

0
44.2
Yield on cost (5-Year) 1.03
MLAB's Yield on cost (5-Year) is ranked lower than
60% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. MLAB: 1.03 )
MLAB' s 10-Year Yield on cost (5-Year) Range
Min: 0.74   Max: 3.84
Current: 1.03

0.74
3.84
Share Buyback Rate -2.90
MLAB's Share Buyback Rate is ranked higher than
74% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.70 vs. MLAB: -2.90 )
MLAB' s 10-Year Share Buyback Rate Range
Min: 6.1   Max: -2.9
Current: -2.9

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.90
MLAB's Price/DCF (Projected) is ranked lower than
54% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. MLAB: 1.90 )
MLAB' s 10-Year Price/DCF (Projected) Range
Min: 0.51   Max: 1.68
Current: 1.9

0.51
1.68
Price/Median PS Value 1.70
MLAB's Price/Median PS Value is ranked lower than
65% of the 268 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. MLAB: 1.70 )
MLAB' s 10-Year Price/Median PS Value Range
Min: 0.42   Max: 1.53
Current: 1.7

0.42
1.53
Price/Peter Lynch Fair Value 2.40
MLAB's Price/Peter Lynch Fair Value is ranked lower than
59% of the 76 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. MLAB: 2.40 )
MLAB' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.38   Max: 3.49
Current: 2.4

0.38
3.49
Earnings Yield (Greenblatt) 3.90
MLAB's Earnings Yield (Greenblatt) is ranked lower than
52% of the 226 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. MLAB: 3.90 )
MLAB' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.4   Max: 20.2
Current: 3.9

3.4
20.2
Forward Rate of Return (Yacktman) 18.73
MLAB's Forward Rate of Return (Yacktman) is ranked higher than
93% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. MLAB: 18.73 )
MLAB' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 8.4   Max: 30.1
Current: 18.73

8.4
30.1

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Mesa Laboratories, Inc. was incorporated under the laws of the State of Colorado on March 26, 1982. It is organized into two divisions across four physical locations. The Instruments Division designs, manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, semiconductor and petrochemical industries. The Biological Indicators Division manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes, including steam, gas, hydrogen peroxide and radiation, in the hospital, dental, medical device and pharmaceutical industries. Its Lakewood, Colorado and Butler, New Jersey facilities manufacture its Instruments Division products, which include the DataTrace, Medical, Bios, Torqo, and Nusonics brands. Its Omaha, Nebraska and Bozeman, Montana locations manufacture its Biological Indicators Division products — the Mesa and Apex brands. The Company's revenues come from two main sources — product sales, and parts and services. Its Instruments Division products include: DataTrace data loggers, which are used in critical manufacturing and quality control processes in the food, pharmaceutical and medical device industries; Medical meters and calibration solutions, which are used for quality control in dialysis clinics and dialysis machine manufacturing operations; Gas flow calibration equipment, which is used for quality control, occupational health and safety, and environmental air monitoring in metrology labs, industrial hygiene and environmental air sampling; Torqo torque testing systems, which are used to measure bottle cap tightness in the beverage and pharmaceutical industries; and Nusonics concentration analyzers, pipeline interface detectors and flow meter products used in the chemical, food, pharmaceutical and plastics industries. Biological indicators consist of resistant spores of certain microorganisms that are applied on a convenient substrate, such as a small piece of filter paper. The spores are well characterized in terms of numbers and resistance to sterilization. In use, the biological indicator is exposed to a sterilization process and then tested to determine the presence of surviving organisms. Its biological indicators include spore strips, which require post-processing transfer to a growth media, self-contained products, which have the growth media already pre-packaged in crushable ampoules, and culture media. Chemical indicators are similar to biological indicators, except that a chemical change (generally determined by color) is used to assess the exposure to sterilization conditions. Biological indicators and chemical indicators are often used together to monitor processes. Biological indicators are used to validate equipment and monitor the effectiveness of a process in any industrial or healthcare sett

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide